News

Companies in the news and how they were assessed

CITY

Rich pickings: Many in the City of London are fretting about the lack of inward investment, but if there is one financial British product North Americans cannot get enough of it’s pensions, says Liam

In rude health: AstraZeneca, Britain’s biggest drugmaker, has “risen to the challenge” of US healthcare providers negotiating drug prices by posting “solid first-half sales growth”, says Derren Nathan

Inflation raises it head: “With new higher [US] tariffs now in force for three months, there was one question that the June consumer price index [CPI] numbers needed to answer – ‘Are tariffs at last b

Issue of the week: populism and central banks ...